logo-loader
viewFinablr PLC

Finablr launches money transfer feature with Samsung Electronics America

The FTSE 250-listed company previously said it continues to invest in the increasing demand for invisible payments by consumers and businesses

Finablr PLC - Finablr launches money transfer feature with Samsung Electronics America
The service allows cross-border payments to 47 countries within Samsung’s native wallet

Finablr PLC (LON:FIN), the payment platform that owns Travelex, has launched a money transfer feature in collaboration with Samsung Electronics America.

The service allows cross-border payments to 47 countries within Samsung’s native wallet Samsung Pay.

READ: Finablr enjoys growth from currency exchange, cross-border payments and B2B

It is available in the US and will expand to “further markets” next year.

“Combining our industry-leading network and pioneering technology with Samsung's leadership in the mobile device market allows us to drive innovation at a scale that is unique in the US$127 trillion global cross border payments market,” said Finablr’s chief executive Promoth Manghat.

The FTSE 250-listed company previously said it continues to invest in the increasing demand for invisible payments by consumers and businesses, driving its strong financial results.

Shares were up 2.53% to 153.8p mid-morning.

Quick facts: Finablr PLC

Price: 11.025 GBX

LSE:FIN
Market: LSE
Market Cap: £77.18 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CytoDyn's therapy used to treat New York coronavirus...

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive the biotech shared positive test results today from seven coronavirus (COVID-19) patients who were treated with the company’s drug leronlimab at a leading medical center in the New York City area. Pourhassan, together diagnostics...

1 day, 1 hour ago

2 min read